phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Mononeuropathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bajpai, A; Bertozzi, F; Gardell, LR; Gaubert, G; Jacobi, PM; Kelly, N; Lameh, J; Nguyen, D; Olsson, R | 1 |
1 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Mononeuropathies
Article | Year |
---|---|
Neuropeptide FF receptors have opposing modulatory effects on nociception.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclic AMP; Disease Models, Animal; Hyperalgesia; Ligands; Male; Mice; Mononeuropathies; NIH 3T3 Cells; Oligopeptides; Pain Measurement; Pain Threshold; Rats; Receptors, Neuropeptide; Small Molecule Libraries; Transfection | 2010 |